PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 52 filers reported holding PMV PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,425,701 | +97984.8% | 3,163,795 | 0.0% | 1.03% | +12.6% |
| Q2 2023 | $19,805 | +31.2% | 3,163,795 | 0.0% | 0.92% | +23.9% |
| Q1 2023 | $15,091 | -99.9% | 3,163,795 | 0.0% | 0.74% | -48.9% |
| Q4 2022 | $27,525,016 | -26.9% | 3,163,795 | 0.0% | 1.45% | -31.5% |
| Q3 2022 | $37,649,000 | -24.5% | 3,163,795 | -9.6% | 2.12% | -33.0% |
| Q2 2022 | $49,856,000 | -31.6% | 3,498,636 | 0.0% | 3.16% | -15.7% |
| Q1 2022 | $72,842,000 | +11.1% | 3,498,636 | +23.3% | 3.74% | +47.1% |
| Q4 2021 | $65,563,000 | -3.0% | 2,838,236 | +25.1% | 2.55% | +7.9% |
| Q3 2021 | $67,593,000 | -12.8% | 2,268,236 | 0.0% | 2.36% | -13.7% |
| Q2 2021 | $77,483,000 | +3.9% | 2,268,236 | 0.0% | 2.73% | +8.1% |
| Q1 2021 | $74,602,000 | -46.5% | 2,268,236 | 0.0% | 2.53% | -43.6% |
| Q4 2020 | $139,519,000 | +73.3% | 2,268,236 | 0.0% | 4.48% | +61.2% |
| Q3 2020 | $80,522,000 | – | 2,268,236 | – | 2.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |